BDBM50148367 2-{(E)-3-[3,5-Bis-(4-trifluoromethyl-benzyloxy)-phenyl]-allyl}-[1,2,4]oxadiazolidine-3,5-dione::CHEMBL116136
SMILES: FC(F)(F)c1ccc(COc2cc(OCc3ccc(cc3)C(F)(F)F)cc(\C=C\Cn3oc(=O)[nH]c3=O)c2)cc1
InChI Key: InChIKey=FZZIBOOHFPOKRX-OWOJBTEDSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tissue-type plasminogen activator (Homo sapiens (Human)) | BDBM50148367 (2-{(E)-3-[3,5-Bis-(4-trifluoromethyl-benzyloxy)-ph...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research Curated by ChEMBL | Assay Description Invitro concentration of the compound required for inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1 at concentrat... | Bioorg Med Chem Lett 14: 3477-80 (2004) Article DOI: 10.1016/j.bmcl.2004.04.058 BindingDB Entry DOI: 10.7270/Q28C9VQ2 | |||||||||||
More data for this Ligand-Target Pair |